Patent Assignment
Reel/Frame 017480/0201
Merger
Recorded: 2006-04-17
Pages: 6
Assignor
EOS BIOTECHNOLOGY, INC.
Executed: 2006-01-09
Assignee
PROTEIN DESIGN LABS, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties
(2)
Methods of Diagnosing Breast Cancer
Patent:
6,762,020 →
Application:
09/642,034 →
Novel Methods of Diagnosing Breast Cancer, Compositions, and Methods of Screening for Breast Cancer Modulators
Patent:
6,649,342 →
Application:
09/657,960 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 22, 2003
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014837/0794 →
Change of Name
Apr 17, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017480/0242 →
Assignment of Assignor's Interest
Mar 4, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022343/0256 →
Change of Name
Dec 9, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025483/0591 →
Change of Name
Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →